Emergent BioSolutions (EBS) Other Gross PP&E Adjustments: 2011-2025
Historic Other Gross PP&E Adjustments for Emergent BioSolutions (EBS) over the last 10 years, with Sep 2025 value amounting to $493.3 million.
- Emergent BioSolutions' Other Gross PP&E Adjustments fell 25.20% to $493.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year decrease of 25.67%. This contributed to the annual value of $656.0 million for FY2024, which is 15.68% down from last year.
- Per Emergent BioSolutions' latest filing, its Other Gross PP&E Adjustments stood at $493.3 million for Q3 2025, which was down 2.89% from $508.0 million recorded in Q2 2025.
- Over the past 5 years, Emergent BioSolutions' Other Gross PP&E Adjustments peaked at $1.2 billion during Q4 2022, and registered a low of $493.3 million during Q3 2025.
- Its 3-year average for Other Gross PP&E Adjustments is $701.2 million, with a median of $693.2 million in 2024.
- As far as peak fluctuations go, Emergent BioSolutions' Other Gross PP&E Adjustments rose by 26.78% in 2021, and later plummeted by 35.02% in 2025.
- Emergent BioSolutions' Other Gross PP&E Adjustments (Quarterly) stood at $1.1 billion in 2021, then increased by 8.35% to $1.2 billion in 2022, then plummeted by 34.18% to $778.0 million in 2023, then fell by 15.68% to $656.0 million in 2024, then dropped by 25.20% to $493.3 million in 2025.
- Its last three reported values are $493.3 million in Q3 2025, $508.0 million for Q2 2025, and $511.2 million during Q1 2025.